Levosimendan 2.5 MG/ML Injectable Solution: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

2

Conditions studied

0

US states with sites

1

Countries

Phase breakdown

Phase 3 1

Conditions being studied

Condition	Trials
Cardiogenic Shock	1
Heart failure	1

Recruiting trials involving Levosimendan 2.5 MG/ML Injectable Solution

Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock
NCT04020263 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 28 locations

Common questions

How many recruiting trials involve Levosimendan 2.5 MG/ML Injectable Solution?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.